Burden & Treatment Considerations For Agitation Associated With Alzheimer’s Dementia

Agitation associated with Alzheimer’s Dementia (AAD) lead to worsening outcomes in an already devastating disease. A patient-centered focus is recommended for a comprehensive treatment plan. In this webinar, the speakers will review the burden of AAD, then discuss current treatment recommendations and unmet needs.

Objectives:

Review the economic and caregiver burden related to agitation associated with Alzheimer’s Disease (AAD)
List the currently available treatment recommendations and guidelines for AAD treatment recommendations
Identify gaps with current treatment options, both pharmacologic and nonpharmacologic